Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Trading update

19 Jul 2017 07:00

RNS Number : 4343L
Haydale Graphene Industries PLC
19 July 2017
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

FOR IMMEDIATE RELEASE

19 July 2017

 

 

Haydale Graphene Industries plc

('Haydale' or the 'Group')

 

Trading update

 

Haydale (AIM: HAYD), the global advanced materials group, announces the following update on trading for the full year ended 30 June 2017 and on the prospects for the Group.

 

Trading update

The Board is pleased to announce that total income for the financial year ended 30 June 2017 is expected to be in line with current market expectations, which represents a doubling when compared with the prior financial year. The Board's decision to increase investment in a number of key areas during the year will result in the Group reporting a marginally higher loss before tax for the full year ('LBT') than originally expected, although the final reported LBT is expected to reduce due to the inclusion of negative goodwill associated with Haydale's acquisition of Advanced Composite Materials Inc. ('ACM') in November 2016.

 

The areas to have benefited from higher investment during the year include the set-up, fit out and recruitment of quality technical and sales staff at Haydale Technologies (Thailand) ('HTT') in Thailand plus the recruitment of executive management at the Group's USA operation. Haydale continues to invest in mixing, dispersion and processing methods for thermoset and thermoplastic resins and polymers.

 

Cash as at 30 June 2017 stood at approximately £2.0 million (31 December 2016: £1.1 million). At the year end, the Group's order book, being product sales orders and consulting contracts to be fulfilled over the next 3.5 years, stood at approximately £5.4 million, which is at record levels for Haydale and provides good visibility on the Group's future income.

 

Strategic Business Units

To streamline the business and to ensure that the Group is best positioned to realise its potential as a commercial entity having evolved from being R&D focused, the Group's operations have been restructured into two Strategic Business Units ('SBU'). The first unit focuses on Resins, Polymers, and Composites which will concentrate on marketing and selling the newly developed graphene infused carbon fibre pre-impregnated materials ('pre-preg'). The second unit, Advanced Materials, principally hosts the Group's silicon carbide ('SiC') products and the newly developed graphene inks and pastes for the self-monitoring blood glucose device market. Each SBU has its own managing director with full profit and loss responsibility and a principal focus on driving product delivery and sales. Supporting each managing director will be dedicated sales teams with technical support.

 

Silicon Carbide

Since Haydale Technologies Inc. ('HTI') acquired ACM in November last year, the Board has been delighted with the progress the Group has made in growing the SiC opportunity. As announced in March 2017, HTI signed an agreement to supply SiC micro-fibre to a new global tooling manufacturer with a potential sales value of over US$2.6 million over its initial four-year term. In addition, other new sales opportunities for SiC micro-fibre include the cook and homeware markets in the Far East, where we are in final trials with a major cookware supplier for improved scratch resistant coatings incorporating Haydale's functionalised graphene and SiC which are showing encouraging results. Due to the increased demand for HTI's SiC micro-fibre, HTI commenced a production run at its facility in Greer, South Carolina, in late May 2017 to replenish its inventory.

 

Huntsman Corporation Agreement update

As previously reported in December 2016 and February 2017, the customer sampling process with Huntsman Corporation ('Huntsman') for graphene infused Araldite® epoxy resin has taken longer than either party originally anticipated. Haydale's investment into research for this exclusive collaboration continues and the Board is encouraged by its progress which, in addition to improving the Group's industry and product know-how, enables Haydale to target new customers already using Huntsman's epoxy resins while Huntsman continues its evaluations.

 

Everpower

Following the investment in Haydale by Everpower earlier this year, both parties have met and agreed that Haydale's products will be supplied to China for testing and sale. These include the full range of the Group's SiC products and functional inks and pastes from Thailand and Taiwan. Data sheets, training and promotional literature has been supplied to Everpower. Additionally, a number of large projects for strategically focused products in the automotive and wind energy sectors are now under evaluation with Everpower for next stage contractual discussions.

 

Post Period End

As announced on 13 July 2017, the Board is delighted to welcome David Banks as our Non-Executive Chairman. In addition to David's appointment, the Group is also pleased to announce the appointment of Keith Broadbent as Managing Director of the Resins, Polymers and Composites SBU. Keith joined Haydale on 17 July 2017 with a track record of implementing increased efficiency and significant bottom line improvement in manufacturing and field installation environments. Keith's experience includes having worked as operations director at Princess Yachts International and at Sunseeker where he was part of the senior management team.

 

To further strengthen our management team Roger Smith, a current Haydale non-executive director, has agreed to take on a part-time executive role assisting with the implementation of Haydale's strategy and supporting business development within each of the Group's SBUs.

 

- Ends -

 

For further information:

Haydale Graphene Industries plc

 

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale-ir.com

Trevor Phillips, Head of Communications

 

 

 

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

 

Tony Rawlinson / Emma Earl

Tel: +44 (0) 20 7213 0880

 

 

Cantor Fitzgerald Europe (Broker)

 

David Foreman / Will Goode (Corporate Finance)

Tel: +44 (0) 20 7894 7000

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Jamie Hooper / Gemma Mostyn-Owen

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA and China and operates from six facilities in the UK, USA and the Far East.

 

For more information please visit:

www.haydale.com

Twitter: @haydalegraphene

 

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

A number of factors could cause actual results to differ materially from the results discussed in the forward looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRDVITLID
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.